Gemtesa 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FSARJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,915
Award facts
- Contract value 100% obligated
- $23,914.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,914.57 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count package) on July 11, 2025, with an ultimate completion date of July 14, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal presence as a critical vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to fulfill diverse medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The award of this delivery order reflects AmerisourceBergen's competitive standing within the federal procurement landscape and its role in supporting the Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DB25FSARJ?
SPE2DB25FSARJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 11, 2025.
How much is contract SPE2DB25FSARJ worth?
The government has obligated $23,915 on SPE2DB25FSARJ.
Is contract SPE2DB25FSARJ an order under another contract?
Yes. SPE2DB25FSARJ is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSARJ competed?
The extent of competition for SPE2DB25FSARJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award